October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Apr 8, 2024, 15:49

Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology

Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X:

“The TRAIN3 trial of MRI-guided TCHP (3, 6 or 9 cycles) is out in The Lancet Oncology. MRI identified patients with HR-/HER2+ breast cancer having pCR after only 3 cycles of TCHP. May it be MRI, PET, GEP, or ctDNA, the future of treatment for HER2+ eBC will be biomarker driven.”

Read further.
Source: Paolo Tarantino/X